Delivery Order SPE2DB25D3012-SPE2DB25FWXVC
Award Date
6/5/25
Potential Completion Date
6/6/25
Potential Value
$15K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,778.90, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ACTIVASE 50 MG VIALS, a medical product, and has a completion date of February 12, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,957,178 units of ACTIVASE 50 MG VIALS. The contract has a firm fixed price of $23,743.76 and an ultimate completion date of April 18, 2025. The contract is not set aside and is an open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 4,567,108,474 units of the drug ACTIVASE 50 MG VIALS. The $4,461.61 firm-fixed-price contract was awarded on January 31, 2025 by the Defense Logistics Agency Troop Support Medical, with a completion date of February 3, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,745.66 firm fixed-price delivery order contract, with a completion date of January 22, 2024, is for 4,563,371,774 units of ACTIVASE 100 MG VIALS. This contract is part of AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a $11,957.40 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for 4567243096 ACTIVASE 50 MG VIALS, a critical medical product, with a period of performance through February 13, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, acting as a prime vehicle for providing a wide range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $42,266.89 firm fixed price delivery order is for the supply of 4,568,373,042 units of ACTIVASE 50 MG VIALS. The contract has an ultimate completion date of May 29, 2025 and is not set aside. AmerisourceBergen Drug Corp is a for-profit company that serves as a critical supplier of medical and pharmaceutical products...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,808,989 units of ACTIVASE 50 MG VIALS. The contract has a completion date of March 1, 2024 and a potential value of $2,864.71. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation associated with this award. This delivery order contract is part of a...
The U.S. federal government awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,560,217 units of the pharmaceutical product ACTIVASE 100 MG VIALS. The contract has a ceiling value of $6,203.51 and an ultimate completion date of May 13, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the Defense Logistics Agency...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,699.37 firm fixed-price delivery order is for the supply of ACTIVASE 50 MG VIALS, with a period of performance extending through March 6, 2025. The contract is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) worth $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $7,669.03 and is a Firm Fixed Price Delivery Order that runs through December 4, 2024. The contract is for the supply of ACTIVASE 100 MG VIALS, a medical product used in healthcare settings. The contract does not have a set-aside designation, indicating open competition....